/Eli Lilly raises 2026 revenue guidance after $23 billion second quarter, details four-drug weight loss pipeline/Mayo Clinic signs Microsoft deal to scale AI diagnostic model, CEO calls for federal action/Precipio Inc. (PRPO) reports $7.0M quarterly revenue record as adjusted EBITDA turns positive/Bitcoin falls to $63,304 as cooling inflation lifts equities but bypasses $BTC/Procter & Gamble's 70-year dividend streak meets a nearly 20% share price retreat/Galaxy cuts CLARITY Act passage odds to 10%/Eli Lilly raises 2026 revenue guidance after $23 billion second quarter, details four-drug weight loss pipeline/Mayo Clinic signs Microsoft deal to scale AI diagnostic model, CEO calls for federal action/Precipio Inc. (PRPO) reports $7.0M quarterly revenue record as adjusted EBITDA turns positive/Bitcoin falls to $63,304 as cooling inflation lifts equities but bypasses $BTC/Procter & Gamble's 70-year dividend streak meets a nearly 20% share price retreat/Galaxy cuts CLARITY Act passage odds to 10%